The global needle-free delivery technology market will reach $2.4 billion in 2017

Monday 3 June 2013, Amsterdam

A new report predicts that the global market for needle-free delivery technology will reach $2.4bn in 2017. That revenue forecast and others appear in Needle-Free Delivery: Technology and Market 2013-2023, published in April 2013.

Needle-free delivery devices will have significant opportunities for growth. We believe market expansion will be driven by new technologies, reduced prices and increasing efficiency in manufacturing processes. Needle-free delivery technology encompasses all delivery technologies which are minimally invasive including jet injectors, microneedles, pen needles, inhalers and patches. Jet injectors are a well established, expanding segment of the market. In addition, innovative technologies such as microneedle patches will drive growth.

Amritha.M.Ramakrishnan, healthcare industry analyst says “The push to develop needle-free technology has largely arisen due to strong demand from patient groups seeking alternatives to traditional needle-based systems. Needle stick injury and needle phobia are the primary factors helping to drive many markets towards the use of needle-free delivery technology. Market growth is also linked to an increase in prevalence of diseases worldwide.

“The overall needle-free technology market is achieving explosive growth and this trend will continue during the forecast period. Needle-free technology offers advantages over conventional technologies including enhanced safety, increased immunogenicity in vaccinations and fewer injection site lesions. Needle-free technology will be increasingly used for mass immunisations and delivery of biologics. However, this will depend upon more clinical evidence becoming available, making the technology more attractive to pharmaceutical companies. The high cost of needle-free technology is another issue currently restraining growth. Despite all of these challenges, experts in the field are optimistic about the opportunities lying ahead for the needle-free market.”

We believe that the overall needle-free technology market will benefit from its extensive development pipeline, with a number of products expected to be launched over the next 10 years. The US is currently the leading national market, while emerging countries like China and India are predicted to play a significant role in the second half of the forecast period.

This report shows revenue forecasts to 2023 at overall world market, submarket and national level. It forecasts world sales for the following submarkets:

•  Jet injectors market
• Competing needle-free technology market

This study also includes forecasts for the following subsectors:

• Novel needle technology (includes microneedles and pen needles)
• Inhaler technology
• Patch technology.

Research, data and analyses cover activities of leading companies, including Antares Pharma, Zogenix, Bioject Medical Technologies and 3M.

The study includes researching trends and forecasting revenues in leading national markets. Countries analysed are the US, Japan, Germany, France, the UK, Spain, Italy, India and China. The analysis also discusses opportunities and developments – technological and commercial.